ATRA
Price
$7.97
Change
-$0.05 (-0.62%)
Updated
Jun 26, 01:07 PM (EDT)
Capitalization
47.81M
PHAT
Price
$9.35
Change
-$0.41 (-4.20%)
Updated
Jun 26, 01:35 PM (EDT)
Capitalization
668.82M
42 days until earnings call
Interact to see
Advertisement

ATRA vs PHAT

Header iconATRA vs PHAT Comparison
Open Charts ATRA vs PHATBanner chart's image
Atara Biotherapeutics
Price$7.97
Change-$0.05 (-0.62%)
Volume$115
Capitalization47.81M
Phathom Pharmaceuticals
Price$9.35
Change-$0.41 (-4.20%)
Volume$915
Capitalization668.82M
ATRA vs PHAT Comparison Chart in %
Loading...
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATRA vs. PHAT commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRA is a Buy and PHAT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (ATRA: $8.02 vs. PHAT: $9.58)
Brand notoriety: ATRA and PHAT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATRA: 26% vs. PHAT: 22%
Market capitalization -- ATRA: $47.81M vs. PHAT: $668.82M
ATRA [@Biotechnology] is valued at $47.81M. PHAT’s [@Biotechnology] market capitalization is $668.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRA’s FA Score shows that 0 FA rating(s) are green whilePHAT’s FA Score has 0 green FA rating(s).

  • ATRA’s FA Score: 0 green, 5 red.
  • PHAT’s FA Score: 0 green, 5 red.
According to our system of comparison, PHAT is a better buy in the long-term than ATRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRA’s TA Score shows that 3 TA indicator(s) are bullish while PHAT’s TA Score has 4 bullish TA indicator(s).

  • ATRA’s TA Score: 3 bullish, 5 bearish.
  • PHAT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PHAT is a better buy in the short-term than ATRA.

Price Growth

ATRA (@Biotechnology) experienced а 0.00% price change this week, while PHAT (@Biotechnology) price change was -12.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.78%. For the same industry, the average monthly price growth was +31.36%, and the average quarterly price growth was +15.04%.

Reported Earning Dates

ATRA is expected to report earnings on May 15, 2025.

PHAT is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+1.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHAT($669M) has a higher market cap than ATRA($47.8M). PHAT YTD gains are higher at: 17.980 vs. ATRA (-39.745). ATRA has higher annual earnings (EBITDA): -5.74M vs. PHAT (-272.12M). PHAT has more cash in the bank: 212M vs. ATRA (13.8M). ATRA has less debt than PHAT: ATRA (40.6M) vs PHAT (204M). ATRA has higher revenues than PHAT: ATRA (200M) vs PHAT (81.9M).
ATRAPHATATRA / PHAT
Capitalization47.8M669M7%
EBITDA-5.74M-272.12M2%
Gain YTD-39.74517.980-221%
P/E RatioN/AN/A-
Revenue200M81.9M244%
Total Cash13.8M212M7%
Total Debt40.6M204M20%
FUNDAMENTALS RATINGS
ATRA: Fundamental Ratings
ATRA
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATRAPHAT
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 18 days ago
82%
Bullish Trend 14 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SO90.40-0.49
-0.54%
Southern Company (The)
BOKF95.06-0.52
-0.54%
BOK Financial Corp
LTC34.59-0.59
-1.68%
LTC Properties
CELU1.88-0.04
-2.08%
Celularity
BTBT2.35-0.09
-3.69%
Bit Digital

ATRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRA has been closely correlated with IKNA. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if ATRA jumps, then IKNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRA
1D Price
Change %
ATRA100%
-0.50%
IKNA - ATRA
72%
Closely correlated
-2.19%
ABCZF - ATRA
53%
Loosely correlated
N/A
RAPT - ATRA
37%
Loosely correlated
+16.30%
PHAT - ATRA
36%
Loosely correlated
-1.84%
ABCL - ATRA
33%
Loosely correlated
+3.26%
More

PHAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHAT has been loosely correlated with TNFA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAT jumps, then TNFA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
-1.84%
TNFA - PHAT
39%
Loosely correlated
-1.57%
ATRA - PHAT
36%
Loosely correlated
-0.50%
PRME - PHAT
35%
Loosely correlated
-1.63%
RGNX - PHAT
35%
Loosely correlated
-0.23%
URGN - PHAT
35%
Loosely correlated
-0.51%
More